Closing remarks - The future of SGLT2 Inhibitor Cardiovascular Outcomes trials: what are we hoping to learn?
Topic:
Pharmacology and Pharmacotherapy
Sponsored by MSD
Event:
ESC Congress 2018
Congress Presentation
About the speakers
Professor Lawrence Leiter
University of Toronto, Toronto (Canada)
19
presentations
0
follower
Doctor Anselm Kai Gitt
Klinikum Ludwigshafen, Ludwigshafen (Germany)
15
presentations
0
follower
3 more presentations in this session
Opening Remarks - The future of SGLT2 Inhibitor Cardiovascular Outcomes trials: what are we hoping to learn?
Speaker: Professor L. Leiter (Toronto, CA) Doctor A. Gitt (Ludwigshafen, DE)
Roundtable discussion: the future of SGLT2i CVOT trials: do we need more data? What are we hoping to learn.
Speaker: Professor L. Leiter (Toronto, CA) Doctor A. Gitt (Ludwigshafen, DE)
Access the full session
The future of SGLT2 Inhibitor Cardiovascular Outcomes trials: what are we hoping to learn?
Speakers:
Professor L. Leiter, Doctor A. Gitt, Professor L. Leiter, Doctor A. Gitt, Doctor A. Gitt...
About the event
